webinar register page

Webinar banner
The World Health Organization (WHO) 2021 Guideline for the Pharmacological Treatment of Hypertension in the Adult: Clinical Implications Donald DiPette, MD, FACP, FAHA
This webinar will review and discuss the important clinical implications of The 2021 WHO Guideline for the Pharmacological Treatment of Hypertension in the Adult. The recommendations include guidance on the blood pressure treatment thresholds and targets once medications have been started including in the general population and considerations in individuals with known cardiovascular disease (CVD), high CVD risk, diabetes mellitus, and chronic kidney disease. Recommendations are also presented as to the classes of antihypertensive medications to be used and consideration of starting two antihypertensive medications in the initial treatment step of the newly diagnosed individual with hypertension. Further recommendations are made regarding the visit follow-up intervals while intensifying medication treatment and once hypertension control is achieved. Finally, recommendations are made regarding obtaining baseline laboratories and CVD risk assessment and the utilization of team-based care.

Presented by Dr. Donald DiPette

Bio
Dr. Donald DiPette is the Health Sciences Distinguished Professor and previous Dean of the University of South Carolina School of Medicine in Columbia, South Carolina.

References
World Health Organization. Guideline for the pharmacological treatment of hypertension in adults. 2021. https://apps.who.int/iris/bitstream/handle/10665/344424/9789240033986-eng.pdf.
Forthcoming

Disclosure
Dr. DiPette did not report any financial relationships or conflicts of interest.

Jun 14, 2022 06:00 PM in Central Time (US and Canada)

Webinar logo
* Required information
Loading